Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications

Dong-Rong Yang1,2, Meng-Yan Wang2, Cheng-Lin Zhang2

  • 1Department of Endocrinology and Metabolism, Shenzhen University General Hospital, Shenzhen, Guangdong, China.

PubMed

Insights

Diabetic vascular complications stem from endothelial dysfunction, impacting quality of life. This review explores mechanisms and pharmacotherapies for diabetic endothelial dysfunction and related vascular diseases.

Area of Science:

  • Vascular Biology
  • Endocrinology
  • Pharmacology

Background:

  • Diabetic vascular complications significantly impact patient quality of life and mortality.
  • These complications arise from endothelial dysfunction driven by hyperglycemia, hypertension, and dyslipidemia.
  • Endothelial dysfunction manifests as inflammation, oxidative stress, reduced nitric oxide, and cellular changes.

Purpose of the Study:

  • To elucidate the mechanisms of endothelial dysfunction in diabetes.
  • To review vascular complications associated with diabetes, including macrovascular and microvascular diseases.
  • To explore pharmacotherapies targeting diabetic endothelial dysfunction for improved therapeutic strategies.

Main Methods:

  • This review synthesizes existing literature on diabetic vascular complications.
  • Mechanisms of endothelial dysfunction are analyzed.
  • Current and potential pharmacotherapies are discussed.

Main Results:

  • Diabetes-induced risk factors trigger endothelial dysfunction, leading to atherosclerosis and basement membrane thickening.
  • Endothelial dysfunction contributes significantly to morbidity and mortality in diabetic patients.
  • Targeting endothelial dysfunction offers a promising avenue for managing diabetic vascular complications.

Conclusions:

  • Understanding the mechanisms of endothelial dysfunction is crucial for developing effective treatments for diabetic vascular complications.
  • Pharmacotherapies targeting endothelial dysfunction hold potential for early control of diabetes and its sequelae.
  • Further research into therapeutic drug discovery is needed to accelerate effective treatments.

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
528
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
924